A New Ossicle Homograft Inactivation/Preservation Procedure: Clinical ResultsRomualdez J.A.a · Stauffer E.b · Häusler R.a · Hotz M.A.a
Departments of aENT, Head and Neck Surgery and bPathology, Inselspital, University of Berne, Berne, Switzerland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
A new NaOH-autoclaving inactivation/preservation procedure (IPP) for ossicle homografts, complying with the actual infectious disease guidelines, has been developed and used in our institution for 5 years. This study compares the clinical and audiological results of middle ear reconstruction using the new NaOH-autoclaving inactivated ossicle homografts (22 patients) and the previously used cialit-formaldehyde inactivation procedure (28 patients). During the follow-up period, no homograft extrusion, resorption or disease transmission was observed either for the NaOH-autoclaving or for the cialit-formaldehyde protocol. A postoperative air-bone gap of less than 20 dB in 44% and a postoperative hearing improvement of 10–50 dB in 70% of patients complies with the published success rates of homograft ossiculoplasty in the literature. The analysis and comparison of both tested IPP-patient groups showed no statistically significant differences in the clinical and the audiological results. The NaOH-autoclaving inactivation/preservation protocol should increase ossicle homograft safety even with respect to prion exposure. The good anatomic and audiological long-term results of the new IPP protocol confirm homograft ossicles as a valid and inexpensive approach for middle ear reconstruction.
© 2005 S. Karger AG, Basel
- Wehrs RE: Homograft ossicles in tympanoplasty. Laryngoscope 1982;92:540–546.
- Chiossone E: Homograft ossiculoplasty: Long term results. Am J Otol 1987;8:545–550.
- Silverstein HA: Comparison of PORP, TORP, and incus homograft for ossicular reconstruction in chronic ear surgery. Laryngoscope 1986;96:159–165.
- Smith MF, Proffitt SD, Shinn JB: An otologic tissue bank. Trans Am Acad Ophthalmol Otolaryngol 1972;76:134–41.
- Steelman, VM: Creutzfeld-Jakob Disease: Recommendations for infection control. AJIC 1994;22:312–318.
- Hotz MA, Orr T, Speirs AD, Häusler R: A new inactivation/preservation procedure for ossicle homografts. Transplant Proc 2002;34:1325–1326.
- Naujoks J, Horning S, Eitschberger E: Eine klinische Studie über allogenetische Ossikelimplantationen. Laryng Rhinol 1978;57:114.
- Lang J, Kerr AG, Smyth GD: Long-term viability of transplanted ossicles. J Laryngol Otol 1986;100:741–747.
- Wehrs RE: Homograft ossicles in middle ear surgery. Am J Otol 1985;6:33–34.
Messerli A, Altermatt HJ, Vischer MW, Häusler R: Incus homograft Ossikuloplastik. Aktuelle Probl Otorhinolaryngol 1994;18:77–85.
- Merchant SN, McKenna MJ, Rosowski JJ: Current status and future challenges of tympanoplasty. Eur Arch Otorhinolaryngol 1998;55:221–228.
- McElveen JT, Friedrichs R, Falk S: Effect of mastoid cavity modification on middle ear sound transmission. Ann Otol Rhinol Laryngol 1982;91:526–532.
- Goode RL, Friedrich R, Falk S: Effect on hearing thresholds of surgical modification of the external ear. Ann Otol 1977;86:441–449.
- Cura O, Kriazli T, Oztop F: Can homograft ossicles still be used in ossiculoplasty? Rev Laryngol Otol Rhinol 2000;121:87.
- Goldenberg RA, Emmet JR: Current use of implants in middle ear surgery. Otol Neurol 2001;22:145–152.
- Hotz MA, Häusler R: Ossicle homografts revisited. Laryngoscope 2003;113:1274–1275.
Minatogawa T, Kumoi T: Problems in utility and safety of otological allografts. Transplant Proc 1999;31:203:6–7.
Bagot d’Arc ML: Oto-rhino-laryngiste et la maladie de Creutzfeld Jakob. Rev Laryngol Otol Rhinol 1998;119:1–12.
- Geyer G: Materials for reconstruction of the middle ear. HNO 1999;47:77–91.
- Merchant SN, Nadol JB. Histopathology of ossicular implants. Otolaryngol Clin North Am 1994;27:813–833.
- Kartush JM: Ossicular chain reconstruction capitulum to malleus. Otolaryngol Clin North Am 1994;27:689–715.
- Williams M, Antonelli P: Middle ear prosthesis displacement in high strength magnetic fields. Otol Neurol 2000;22:158–161.
- van Blitterswijk CA, Grote JJ: Biocompatibility of clinically applied hydroxyapatite ceramic. Ann Otol Rhinol Laryngol Suppl 1990;144:3–11.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.